Insmed (INSM) Accumulated Expenses (2010 - 2026)

Insmed's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $162.1 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 1381.92% year-over-year to $162.1 million; the TTM figure through Mar 2026 stood at $162.1 million (up 1381.92% YoY), while the FY2025 annual figure was $17.1 million, down 89.55% from the prior year.
• Accumulated Expenses was $162.1 million for Q1 2026 at Insmed, up from $17.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $163.7 million in Q4 2024 to a low of $6.0 million in Q3 2023.
• Historically, Accumulated Expenses has averaged $77.0 million across 5 years, with a median of $37.9 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Accumulated Expenses sank 95.21% in 2024, then soared 1381.92% in 2026.
• A 5-year view of Accumulated Expenses shows it stood at $151.5 million in 2022, then climbed by 4.37% to $158.2 million in 2023, then increased by 3.48% to $163.7 million in 2024, then sank by 89.55% to $17.1 million in 2025, then surged by 848.11% to $162.1 million in 2026.
• The last three Accumulated Expenses figures came in at $162.1 million (Q1 2026), $17.1 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.